Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117227) titled 'Effects of Ultrasound-Guided Stellate Ganglion Block Combined with Esketamine on Anxiety, Depression, and Sleep in Postpartum Women After Cesarean Section' on Jan. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Third People's Hospital of Bengbu
Condition:
anxiety, depression
Intervention:
Ultrasound-guided stellate ganglion block + esketamine group:The combined analgesia regimen consisted of ultrasound-guided stellate ganglion block with 3 ml of 0.5% ropivacaine, plus a patient-controlled intravenous analgesia (PCIA) pump containing esketamine at a dose of 0.5 mg/kg
Recrui...